Renee Marie Chin, MD

Wei Seong Tan, MD, is a medical practice situated in New Hyde Park, NY, dedicated to providing exceptional healthcare services to patients in the area. With a focus on delivering personalized and compassionate care, this practice offers a range of medical treatments, from routine check-ups to specialized procedures, to meet the diverse needs of its patients. Dr. Wei Seong Tan and their team of skilled healthcare professionals strive to uphold the highest standards of medical excellence while fostering a warm and welcoming environment for individuals seeking quality healthcare. At Wei Seong Tan, MD, patients can expect to receive comprehensive medical services tailored to their unique health requirements. Through a patient-centered approach, the practice aims to enhance the well-being of individuals by offering expert medical guidance, innovative treatments, and ongoing support. Dr. Wei Seong Tan's commitment to excellence in healthcare is reflected in their dedication to staying abreast of the latest advancements in medicine and providing top-notch care that prioritizes the health and satisfaction of every patient who walks through their doors. Generated using this brand's available information

I am a pediatric hematologist/oncologist who specializes in stem cell transplantation and cellular therapy. I graduated from the Upstate Medical University, completed a residency in pediatrics at the Schneider Children's Hospital, served as Chief Resident of Pediatrics at the Schneider Children's Hospital, and then completed my training with a fellowship in pediatric hematology / oncology at the Children s Hospital of Philadelphia. During my fellowship, I concurrently spent 3 years in the laboratory researching cellular immunotherapy for acute lymphoblastic leukemia, while also pursuing a clinical interest in the late effects of childhood cancer treatment. In 2008 I came to the Cohen Children s Medical Center to found Survivors Facing Forward, a long-term follow-up program to provide care to survivors of childhood cancer and stem cell transplantation. Since 2008, the program has grown to follow nearly 1,000 survivors of childhood cancer and has been a fertile source for clinical research. In 2021 I assumed leadership of the stem cell transplantation and cellular therapy program at Cohen Children's Medical Center, where I am the Transplant Center Medial Director and Marrow Collection Facility Director. Our transplant center participates in national and international cooperative group studies in the use of stem cell transplantation and cellular therapy to treat cancers, bone marrow failure syndromes, immune deficiencies and hemoglobinopathies (sickle cell disease and thalassemia). Notably, we are one of a very limited number of Qualified Treatment Centers (QTC) for Zynteglo , an FDA approved gene therapy for transfusion dependent thalassemia, and are in the process of being named a QTC for gene therapy products recently FDA approved to cure sickle cell disease.